Breaking News
Get 60% Off 0
📈 Q2 Earnings Alert! Plan ahead with key data on upcoming stock reports - all in 1 place
See Economic Calendar
Close

Microbot Medical Inc (MBOT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Microbot Medical's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.750 -0.040    -2.23%
15:59:59 - Closed. Currency in USD
After Hours
1.792
+0.042
+2.400%
19:49:44 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 742,527
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.740 - 1.790
Microbot Medical 1.750 -0.040 -2.23%

MBOT Recent Sentiments

 
This page contains information on users’ sentiments for the Microbot Medical Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Jul 10, 2026 Lapinou 44   1.880 Jul 13, 2026 @ 1.875 -0.27%
Jul 06, 2026 luis martinez   1.950 -10.26%
Jul 02, 2026 David Baker   1.935 -9.56%
Jun 29, 2026 Samuel Vuistiner   1.860 -5.91%
Jun 29, 2026 JAUME BOU BELLIDO   1.850 -5.41%
Jun 23, 2026 Peter Weiss   1.815 Jul 17, 2026 @ 1.742 -4.02%
Jun 16, 2026 Sig Lock   1.855 Jul 10, 2026 @ 1.895 +2.16%
Jun 09, 2026 Sue Wicki   1.800 Jul 03, 2026 @ 1.910 +6.11%
Jun 04, 2026 Moataz Moataz   2.000 Jun 26, 2026 @ 1.780 -11.00%
Jun 03, 2026 Paolo Greci   1.965 Jun 26, 2026 @ 1.780 -9.41%
Jun 01, 2026 Inhwan Choi   2.090 Jun 01, 2026 @ 2.015 -3.59%
May 29, 2026 arjan Olomani   2.145 Jun 19, 2026 @ 1.860 -13.29%
May 29, 2026 Samuel Vuistiner   2.150 Jun 19, 2026 @ 1.860 -13.49%
May 28, 2026 J M   1.950 Jun 19, 2026 @ 1.860 -4.62%
May 28, 2026 Juanjo Marín   1.880 Jun 01, 2026 @ 2.015 +7.18%
May 27, 2026 Victor Zamorano   1.755 Jun 01, 2026 @ 2.015 +14.81%
May 26, 2026 daniel el travieso   1.810 Jun 19, 2026 @ 1.860 +2.76%
May 20, 2026 Mina Nuñez   1.755 Jun 12, 2026 @ 1.785 +1.71%
May 19, 2026 Victor Zamorano   1.000 May 25, 2026 @ 1.710 -71.00%
May 15, 2026 Samuel Vuistiner   1.895 May 28, 2026 @ 1.930 +1.85%
May 14, 2026 Sue Wicki   1.860 Jun 05, 2026 @ 1.845 -0.81%
May 08, 2026 Victor Zamorano   2.000 May 11, 2026 @ 2.160 +8.00%
May 07, 2026 Rob Kroone   2.110 May 29, 2026 @ 2.035 -3.55%
May 04, 2026 Samuel Vuistiner   2.105 May 12, 2026 @ 2.145 +1.90%
Apr 28, 2026 Kevin Camacho...   2.110 May 22, 2026 @ 1.710 +18.96%
Apr 22, 2026 Victor Zamorano   2.000 Apr 27, 2026 @ 2.170 +8.50%
Apr 20, 2026 Kevin Camacho...   2.270 Apr 28, 2026 @ 2.095 +7.71%
Apr 20, 2026 필재 허   2.290 Apr 27, 2026 @ 2.170 -5.24%
Apr 16, 2026 Terk One   2.370 May 08, 2026 @ 2.135 +9.92%
Apr 14, 2026 Javier Garcia   2.465 May 08, 2026 @ 2.135 -13.39%
Apr 13, 2026 Victor Zamorano   2.370 Apr 20, 2026 @ 2.280 -3.80%
Apr 10, 2026 필재 허   2.520 Apr 13, 2026 @ 2.339 -7.18%
Apr 07, 2026 Alberto Alberti   2.315 May 01, 2026 @ 2.100 -9.29%
Apr 06, 2026 Lapinou 44   2.420 Apr 06, 2026 @ 2.440 +0.83%
Mar 31, 2026 Juanjo Marín   2.360 Apr 06, 2026 @ 2.440 +3.39%
Mar 26, 2026 Kevin Camacho...   2.730 Apr 17, 2026 @ 2.345 -14.10%
Mar 24, 2026 Rita Luis Sanz   2.465 Mar 30, 2026 @ 2.335 -5.27%
Mar 17, 2026 Samuel Vuistiner   2.740 Apr 10, 2026 @ 2.585 -5.66%
Mar 16, 2026 Juanjo Marín   2.725 Mar 23, 2026 @ 2.510 -7.89%
Mar 16, 2026 Junhyung Lee   2.750 Mar 23, 2026 @ 2.510 -8.73%
Mar 12, 2026 Lapinou 44   2.790 Mar 16, 2026 @ 2.725 -2.33%
Mar 11, 2026 Juanjo Marín   2.710 Mar 16, 2026 @ 2.725 +0.55%
Mar 11, 2026 Amit Kalo   2.745 Apr 03, 2026 @ 2.400 -12.57%
Mar 06, 2026 Peter Weiss   2.380 Mar 27, 2026 @ 2.390 +0.42%
Feb 26, 2026 Roberto Uloremi   2.590 Mar 02, 2026 @ 2.405 -7.14%
Feb 25, 2026 Ami Noni   2.565 Mar 20, 2026 @ 2.530 -1.36%
Feb 25, 2026 Rita Luis Sanz   2.000 Mar 02, 2026 @ 2.405 +20.25%
Feb 24, 2026 רועי שוב   2.490 Mar 20, 2026 @ 2.530 +1.61%
Feb 24, 2026 Kevin Camacho...   2.475 Mar 20, 2026 @ 2.530 +2.22%
Feb 24, 2026 iñigo Usandizaga...   2.450 Mar 02, 2026 @ 2.405 -1.84%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MBOT Comments

Write your thoughts about Microbot Medical Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Peter Weiss
Peter Weiss Jun 23, 2026 2:03PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Strange… more contracts and sales and value low and going down ….
ram pepe
ram pepe Sep 29, 2025 10:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Abandon the value, it contributes nothing, they just want our money
ram pepe
ram pepe Sep 29, 2025 10:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Since I joined, I've only been losing ground. I think it's a disastrous choice. And I repeat, you can't go on stage without well-written roles. You don't sell anything that way.
ram pepe
ram pepe Sep 29, 2025 10:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Not a very positive action, either the big hands take it or it collapses, because the marketing has been poor.
ram pepe
ram pepe Sep 29, 2025 10:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The CEO's terrible performance has resulted in a 20% devaluation of the stock. You have to know how to work with the timing; the market is wise and has made you pay. It's hard to recover this 20%.
J Collier
J Collier Sep 15, 2025 10:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
following the much awaited FDA approval: short covering spike, then weak hands taking profits, now sellers who are now convinced low chance of a bigger player buyout
Sachin Patel
Sachin Patel Feb 27, 2025 1:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Liberty is a game changer for endovascular procedures. Crazy medical tech!
Sachin Patel
Sachin Patel Jan 27, 2025 11:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Game changer!!
Simon Chang
Simon Chang Jan 17, 2025 3:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I like this little medical robotics company. Seems to have potential.
Bernat Balsells
Bernat Balsells Jun 03, 2024 10:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
seem its unfolding now
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email